These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9328115)

  • 1. Characteristics of asymptomatic secondary immune responses to measles virus in late convalescent donors.
    Huiss S; Damien B; Schneider F; Muller CP
    Clin Exp Immunol; 1997 Sep; 109(3):416-20. PubMed ID: 9328115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles virus protein-specific IgM, IgA, and IgG subclass responses during the acute and convalescent phase of infection.
    El Mubarak HS; Ibrahim SA; Vos HW; Mukhtar MM; Mustafa OA; Wild TF; Osterhaus AD; de Swart RL
    J Med Virol; 2004 Feb; 72(2):290-8. PubMed ID: 14695672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of measles virus from a naturally-immune, asymptomatically re-infected individual.
    Vardas E; Kreis S
    J Clin Virol; 1999 Aug; 13(3):173-9. PubMed ID: 10443793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimated susceptibility to asymptomatic secondary immune response against measles in late convalescent and vaccinated persons.
    Damien B; Huiss S; Schneider F; Muller CP
    J Med Virol; 1998 Sep; 56(1):85-90. PubMed ID: 9700638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles antibodies in nasal secretions and sera of children with measles.
    Polna I; Aleksandrowicz J; Krawczyński K; Krotochwil-Skrzypek M; Rozskowska K
    Acta Virol; 1977 Jul; 21(4):331-7. PubMed ID: 20768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive hemagglutination test for measles immunity and serodiagnosis.
    Sakata H; Sugiura A
    J Clin Microbiol; 1988 Apr; 26(4):636-40. PubMed ID: 3130389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of adsorbents on IgM and IgG measles antibodies.
    Polna I; Aleksandrowicz J
    Acta Virol; 1975 Nov; 19(6):449-56. PubMed ID: 1989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing B cell response in measles.
    Bouche FB; Ertl OT; Muller CP
    Viral Immunol; 2002; 15(3):451-71. PubMed ID: 12479395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the neutralizing antibody response to the measles virus using synthetic peptides of the haemagglutinin protein.
    Muller CP; Schroeder T; Tu R; Brons NH; Jung G; Schneider F; Wiesmüller KH
    Scand J Immunol; 1993 Nov; 38(5):463-71. PubMed ID: 7694357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A solid-phase radioimmunoassay for IgG and IgM antibodies against measles virus.
    Arstila P; Vuorimaa T; Kalimo K; Halonen P; Viljanen M; Granfors K; Toivanen P
    J Gen Virol; 1977 Jan; 34(1):167-76. PubMed ID: 833576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles virus-specific immunoglobulin G isotype immune response in early and late infections.
    Isa MB; Martínez L; Giordano M; Zapata M; Passeggi C; De Wolff MC; Nates S
    J Clin Microbiol; 2001 Jan; 39(1):170-4. PubMed ID: 11136766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunoassay of measles virus antibodies in SSPE.
    Jankowski MA; Gut W; Kańtoch M
    Acta Virol; 1982 Dec; 26(6):481-7. PubMed ID: 6132542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary immune response in a vaccinated population during a large measles epidemic.
    Ozanne G; d'Halewyn MA
    J Clin Microbiol; 1992 Jul; 30(7):1778-82. PubMed ID: 1629334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of measles nucleoprotein in different expression systems and its use as a diagnostic reagent.
    Warnes A; Fooks AR; Stephenson JR
    J Virol Methods; 1994 Oct; 49(3):257-68. PubMed ID: 7868644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies.
    Muñoz-Alía MA; Casasnovas JM; Celma ML; Carabaña J; Liton PB; Fernandez-Muñoz R
    Virus Res; 2017 May; 236():30-43. PubMed ID: 28465158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-exposure to wild-type virus stabilizes measles-specific antibody levels in late convalescent patients.
    Kremer JR; Bouche FB; Schneider F; Muller CP
    J Clin Virol; 2006 Jan; 35(1):95-8. PubMed ID: 16137922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monospecific antibody to the haemagglutinin of measles virus.
    McFarlin DE; Bellini WJ; Mingioli ES; Behar TN; Trudgett A
    J Gen Virol; 1980 Jun; 48(Pt 2):425-9. PubMed ID: 6156998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles vaccine: immunity, reinfection and revaccination.
    Linnemann CC
    Am J Epidemiol; 1973 Jun; 97(6):365-71. PubMed ID: 4713932
    [No Abstract]   [Full Text] [Related]  

  • 19. Adaptation of a commercially available indirect fluorescent antibody slide test for measuring measles-specific immunoglobulins.
    Kleiman MB; Bockhold CA; Zimmerman SE; Griffin C; French ML; Barrett C
    Diagn Microbiol Infect Dis; 1986 Apr; 4(4):285-90. PubMed ID: 3516550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.
    Iankov ID; Pandey M; Harvey M; Griesmann GE; Federspiel MJ; Russell SJ
    J Virol; 2006 Sep; 80(17):8530-40. PubMed ID: 16912303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.